Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing ...

AbbVie (NYSE: ABBV) shares lost ground Friday. The company announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion ...

Committee for Human Medicinal Products (CHMP) recommended approval of five novel medicines at its September meeting ...

Safety Assessment Program has published peer-reviewed safety assessments covering over 2,000 fragrance materials in the peer-reviewed ...

Amid a parade of regulatory endorsements in Europe, Apellis Pharmaceuticals’ ophthalmology prospect pegcetacoplan has been ...

TIME's senior sports correspondent Sean Gregory tries his hand at several Olympic sports while learning from Olympians. Subscribe now to get unlimited access to TIME.com and more! Tidal action ...

With less than 50 days until voters take to the polls, second gentleman Doug Emhoff has been on the campaign trail supporting his wife, Vice President Kamala Harris, as she campaigns to be the ...

A shortlist of the biggest headlines, recommended stories, and a special collection of news items that you should check out.

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...

Estranged couple blame each other for a gun battle at Russia’s most successful online retailer that killed two and wounded seven ...